Friendly flora to promote intestinal balance
Description:
Each Multi-Probiotic 4000 capsule, provided byDouglas Laboratories, contains over four billionbeneficial organisms, including representatives ofboth the lactobacillus and bifidobacterium genera,mixed in a base of prebiotic fructooligosaccharide.
Health Functions:
Oral supplements of live, beneficial intestinal microorganismsfor nutritional health and well-being areknown as probiotics. Probiotic dietary lactobacillicolonize the intestinal tract, depending on the specificbacterium-to-host affinity. Bacteria are continually incompetition for colonization space. The originalbacterial colonies have an advantage over transientbacteria. Nevertheless, the composition of theintestinal microflora is dynamic and constantlychangingIf harmful microorganisms proliferate, theequilibrium is disturbed, and it becomes difficulteven for indigenous bacteria to maintain theirnecessary territory to colonize the intestine.Antibiotics tend to kill off both beneficial andharmful bacteria and thus may also disturb thenormal, healthy balance of intestinal microorganisms. When potent probiotic supplements, such as Multi-Probiotic 4000, are supplied regularly, chances aregreatly increased for establishing and maintaining ahealthy population of beneficial intestinalmicroorganisms. Once established, a normalintestinal microflora rich in lactobacilli creates acidicconditions that are unfavorable for the settlement ofpathogenic microorganisms. Ingredients:
Formula(#7497-100X)
Each Multi-Probiotic 4000 capsule contains over 4billion (4000 x 1 million) organisms in thefollowing potencies:
Lactobacillus. acidophilus (DDS-1™) 1.15 Billion,L. Rhamnosus 1.15 Billion,L. Rhamnosus (Type B, Bifidus) 775 Million,Bifidobacterium lactis 275 Million,Bifidobacterium longum 275 Million,B. Bifidum 275 Million,Streptococcus thermophilus 150 Million.
In a base of FOS (fructooligosaccharides), specialcarbohydrates, enzymes and ulmus fulva
Servings:
Adults take 1 capsule daily or as directed byphysician.
Caution:
No adverse effects have been reported.
Store in a cool, dry place, away from direct light. Keep out of reach of children.
Disclaimer:
The Food and Drug Administration has not evaluated statements contained herein. These products are not intended to diagnose, treat and cure or prevent disease. Always consult with your professional health care provider before changing any medication.
References:
- Cebra JJ. Influences of microbiota on intestinal immune systemdevelopment. Am J Clin Nutr 1999;69:1046S-1051S.
- Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics:approaches for modulating the microbial ecology of the gut. Am JClin Nutr 1999;69:1052S-1057S.
- Donnet-Hughes A, Rochat F, Serrant P, Aeschlimann JM, SchiffrinEJ. Modulation of nonspecific mechanisms of defense by lacticacid bacteria: effective dose. J Dairy Sci 1999;82:863-9.
- Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents.A neglected modality for the treatment and prevention of selectedintestinal and vaginal infections . Jama1996;275:870-6.
- Gibson GR. Dietary modulation of the human gut microflora usingprebiotics. Br J Nutr 1998;80:S209-12.
- Goldin BR. Health benefits of probiotics. Br J Nutr 1998;80:S203-7.
- Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL,Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M, JakobsenM. Screening of probiotic activities of forty-seven strains oflactobacillus spp. by In vitro techniques and evaluation of thecolonization ability of five selected strains in humans [In ProcessCitation]. Appl Environ Microbiol 1999;65:4949-56.
- Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. Theability of probiotic bacteria to bind to human intestinal mucus.FEMS Microbiol Lett 1998;167:185-9.
- Pessi T, Sutas Y, Saxelin M, Kallioinen H, Isolauri E.Antiproliferative effects of homogenates derived from five strainsof candidate probiotic bacteria [In Process Citation]. Appl EnvironMicrobiol 1999;65:4725-8.
- Tejada-Simon MV, Lee JH, Ustunol Z, Pestka JJ. Ingestion ofyogurt containing Lactobacillus acidophilus and Bifidobacteriumto potentiate immunoglobulin A responses to cholera toxin in mice.J Dairy Sci 1999;82:649-60.
- Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E,Brigidi P, Matteuzzi D, Campieri M. Impact on the composition ofthe faecal flora by a new probiotic preparation: preliminary data onmaintenance treatment of patients with ulcerative colitis. AlimentPharmacol Ther 1999;13:1103-8.
- Wang X, Ma G, Zheng B, Tian H. [Effects of SL-probioticpreparation on the body weight and phagocytosis of white mice].Wei Sheng Wu Hsueh Pao 1995;35:455-9.
|
